Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy
- 30 November 2005
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 150 (5) , 986.e1-986.e7
- https://doi.org/10.1016/j.ahj.2005.07.021
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardiumNature, 2004
- Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarctsNature, 2004
- Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytesJournal of Clinical Investigation, 2001
- Bone marrow cells regenerate infarcted myocardiumNature, 2001
- Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac functionNature Medicine, 2001
- Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheepNature Medicine, 2000
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Cardiomyocytes can be generated from marrow stromal cells in vitroJournal of Clinical Investigation, 1999
- Molecular and Cellular Mechanisms of Myocardial FailureThe American Journal of Cardiology, 1997
- Chronic stunning: The new switch in thoughtBasic Research in Cardiology, 1995